Geron

$1.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-2.65%) Today

-$0.02 (-1.36%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Geron and other stocks, options, and ETFs commission-free!

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

CEO

John A. Scarlett

Employees

Headquarters

Foster City, California

Founded

1990

Market Cap

440.33M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.19M

High Today

$1.51

Low Today

$1.44

Open Price

$1.51

Volume

1.68M

52 Week High

$2.40

52 Week Low

$1.10

GERN Earnings

-$0.20

-$0.13

-$0.07

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 27, After Hours